Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 medications, including semaglutide and tirzepatide, are classified as prescription drugs by the FDA because they carry clinical effects that require medical oversight. PlexusDx operates within this legal framework by connecting patients with licensed providers who evaluate candidacy, monitor progress, and adjust treatment based on individual response.

Why GLP-1 Medications Require a Prescription

Semaglutide and other GLP-1 receptor agonists are prescription-only because they actively lower blood sugar, reduce appetite signaling in the brain, and slow gastric emptying. The FDA mandates prescriber oversight for any medication that alters these physiological processes, since individual health status—including kidney function, pancreatitis history, and medication interactions—must be evaluated beforehand. This regulatory requirement exists to prevent adverse outcomes in patients with contraindications.

A licensed physician reviews your medical history, current medications, and weight loss goals before issuing a prescription. This consultation step ensures the medication matches your specific health profile and that you understand potential side effects like nausea, vomiting, or rare but serious conditions such as medullary thyroid cancer risk in susceptible populations. The prescription requirement is not a barrier—it is a safeguard built into the medication's legal status.

How PlexusDx Streamlines the Prescription Process

PlexusDx eliminates the friction of traditional weight loss clinics by offering virtual consultations with licensed physicians who specialize in GLP-1 therapy. Patients complete a health questionnaire, connect with a provider, and receive a prescription—all without requiring insurance or membership fees. The entire process is designed to respect both regulatory requirements and patient convenience, with access available across all 50 states.

Once a prescription is issued, PlexusDx sources compounded medications from licensed 503A compounding pharmacies, which are regulated facilities that prepare custom formulations under strict quality standards. Your dose may need to go up as your body adjusts, but your price stays the same—semaglutide starts at $149 per month, flat, regardless of the dose strength prescribed. This transparent pricing model removes the guesswork around treatment costs.

Prescription vs. Over-the-Counter: Understanding the Difference

Unlike vitamins or herbal supplements sold over-the-counter, GLP-1 medications are pharmaceuticals that directly influence metabolic hormones and must be prescribed by a licensed healthcare provider. The FDA does not allow these compounds to be sold without a prescription because their safety profile depends on proper patient selection, dosing titration, and medical monitoring. Attempting to obtain GLP-1 medications without a valid prescription is illegal and carries significant health risks.

Some online platforms may claim to bypass the prescription requirement, but legitimate medical providers—including PlexusDx—will not dispense these medications without a physician consultation. The prescription requirement reflects the medication's potency and the importance of professional oversight. Patients who want access to GLP-1 therapy should work with accredited telemedicine providers or in-person clinics that follow FDA and state pharmacy regulations.

What Happens After You Receive Your GLP-1 Prescription

After your prescription is issued, PlexusDx ships your medication directly to your home, along with sterile injection supplies if you choose the injectable formulation. Patients using semaglutide injection typically start at a low dose and titrate upward every four weeks under provider guidance, with check-ins scheduled to assess tolerance and weight loss progress. This ongoing oversight ensures you remain safe and that any side effects are managed promptly.

The Precision Peptide Genetic Test ($99 add-on after your first month) can further personalize your therapy by revealing genetic variants in peptide pathways—including markers like GLP1R rs6923761 and GIPR rs1800437—that influence how your body responds to GLP-1 compounds. This data helps your PlexusDx provider fine-tune your treatment plan, potentially improving outcomes compared to a one-size-fits-all approach. Your prescription remains valid throughout your treatment relationship, with annual renewal as required by state law.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I buy GLP-1 medication without a prescription?

No. All GLP-1 medications, including semaglutide and tirzepatide, are schedule-controlled pharmaceuticals that require a valid prescription from a licensed physician. PlexusDx ensures you receive a legitimate prescription through a telemedicine consultation before any medication is dispensed.

What do I need to qualify for a GLP-1 prescription?

Typically, you need a BMI ≥30 or BMI ≥27 with weight-related health conditions, combined with realistic weight loss goals and no major contraindications (such as personal/family history of medullary thyroid cancer or multiple endocrine neoplasia).

Does PlexusDx require insurance to prescribe GLP-1?

No. PlexusDx serves all 50 states without requiring insurance, membership fees, or insurance approval. Your semaglutide prescription costs a flat $149 per month, and payments are HSA/FSA eligible if you have those accounts.

Are compounded GLP-1 medications from PlexusDx as safe as brand-name drugs?

Yes. PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which follow FDA and state pharmacy board regulations for quality, sterility, and potency. Compounded semaglutide and tirzepatide contain the same active pharmaceutical ingredients as brand medications but are custom-prepared and more affordable.

How does the Precision Peptide Genetic Test improve my GLP-1 prescription?

The test ($99 after your first month) reveals genetic variants in 14 peptide pathways and 49 peptides, including GLP1R and GIPR markers that predict your individual response to GLP-1 therapy. This data helps your provider adjust your specific prescription and dosing strategy for better weight loss results and fewer side effects.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves